共 282 条
- [43] Bilateral visual outcomes and service utilization of patients treated for 3 years with ranibizumab for neovascular age-related macular degeneration [J]. CLINICAL OPHTHALMOLOGY, 2014, 8 : 717 - 723
- [44] TYPE 1 VERSUS TYPE 3 NEOVASCULARIZATION IN PIGMENT EPITHELIAL DETACHMENTS ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY A Prospective Study [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (12): : S50 - S64
- [46] FUNDUS AUTOFLUORESCENCE NOT PREDICTIVE OF TREATMENT RESPONSE TO INTRAVITREAL BEVACIZUMAB IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2012, 32 (08): : 1465 - 1470
- [47] Chiam PJ, 2016, INT J OPHTHALMOL-CHI, V9, P551, DOI 10.18240/ijo.2016.04.12
- [49] RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (10): : 1851 - 1859